Dianthus Therapeutics, Inc. /DE/ DNTH
CIK 0001690585
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $1.45M
- Sold
- $69.88M
Sep 1, 2023 – Sep 3, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-09-01 | Randhawa Simrat EVP, Head of R&D | Sale10b5-1 footnote | $2.46M 23,124 shares sold | 85.25% sold Direct holding | ▾ |
| 2026-08-19 | Read Simon Director | Sale10b5-1 footnote | $326.55K 2,778 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-08-10 | McGeorge Anne Director | Sale10b5-1 footnote | $844.82K 7,750 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-08-10 | Veness Adam M SVP, General Counsel and Sec. | Sale10b5-1 footnote | $1.78M 16,167 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-08-10 | Read Simon Director | Sale10b5-1 footnote | $304.23K 2,777 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-08-07 | Veness Adam M SVP, General Counsel and Sec. | Sale10b5-1 footnote | $424.32K 3,833 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-08-07 | Garcia Marino CEO AND PRESIDENT · Director | Sale10b5-1 footnote | $17.95M 166,000 shares sold | Unavailable Direct holding | ▾ |
| 2026-07-09 | Savitz Ryan EVP, CFO & CBO | Sale10b5-1 footnote | $3.16M 31,249 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-06-17 | Veness Adam M SVP, General Counsel and Sec. | Sale10b5-1 footnote | $2.42M 30,000 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-06-01 | Randhawa Simrat EVP, Head of R&D | Sale10b5-1 footnote | $2.40M 26,530 shares sold | 86.90% sold Direct holding | ▾ |
Showing 18 / 18 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 18 of 18 purchase / sale groups and 30 of 66 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"DNTH","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.